Livedo Reticularis – A Complete Guide

What is Livedo reticularis?

Livedo reticularis (pronounced “liv‑dee‑oh reh‑ti‑koo‑LAR‑is”) is a skin finding characterized by a net‑like, reddish‑purple or bluish discoloration that forms a reticular (lattice‑like) pattern on the surface of the skin. The pattern typically appears on the legs, arms, torso, or buttocks and may become more noticeable in cold temperatures or when a person is standing for a long time.

The discoloration results from altered blood flow within the tiny blood vessels (capillaries and venules) of the skin. When blood pools or slows down, deoxygenated blood gives the skin its characteristic mottled hue. In many people the condition is harmless and temporary, but it can also be a sign of an underlying systemic disease.

Sources: Mayo Clinic; NIH.

Common Causes

While livedo reticularis can appear idiopathically (without a known cause), it is frequently associated with other medical conditions. Below are the most common causes, grouped by category:

• Physiologic (benign) causes
  • Cold‑induced vasospasm (often simply called “livedo rosacea” or “physiologic livedo”)
  • Prolonged standing or immobility that reduces venous return
• Hematologic disorders
  • Antiphospholipid syndrome (APS)
  • Hypercoagulable states (e.g., factor V Leiden, protein C/S deficiency)
  • Polycythemia vera
  • Thrombotic thrombocytopenic purpura (TTP)
• Connective‑tissue / autoimmune diseases
  • Systemic lupus erythematosus (SLE)
  • Dermatomyositis
  • Scleroderma (systemic sclerosis)
  • Rheumatoid arthritis (rarely)
• Vasculitic and vasculopathy conditions
  • Sneddon syndrome (livedo with cerebrovascular events)
  • Cutaneous leukocytoclastic vasculitis
  • Primary antiphospholipid antibody–mediated vasculopathy
• Infectious causes
  • Acute viral infections (e.g., hepatitis B/C, HIV)
  • Bacterial endocarditis
• Medication‑induced
  • Amantadine, interferon‑α, quinine, oral contraceptives, and certain chemotherapeutic agents
• Other systemic conditions
  • Chronic kidney disease (uremic pruritus can coexist)
  • Peripheral arterial disease

Associated Symptoms

Because livedo reticularis often reflects vascular or systemic disease, it may be accompanied by other signs and symptoms, depending on the underlying cause.

• Skin pain, burning, or itching where the pattern appears
• Ulcerations or necrotic (black) spots in severe cases (livedoid vasculopathy)
• Generalized fatigue or malaise
• Joint pain or swelling (common in connective‑tissue diseases)
• Neurologic complaints – headaches, transient ischemic attacks, or strokes (Sneddon syndrome)
• Fever, night sweats, or unexplained weight loss (possible infection or malignancy)
• Easy bruising or prolonged bleeding (coagulopathies)
• Pain or swelling in the legs (deep‑vein thrombosis)

When to See a Doctor

Most cases of livedo reticularis are benign and improve with warmth, but you should seek medical attention if any of the following occur:

• The mottled pattern is painful, rapidly spreading, or becomes fixed (does not improve with warming).
• You notice ulcerations, blisters, or blackened skin.
• Accompanying symptoms such as unexplained fever, night sweats, weight loss, or persistent joint pain develop.
• Neurologic signs appear – sudden weakness, vision changes, or confusion.
• History of clotting disorders, autoimmune disease, or recent use of medications known to cause livedo.
• The rash persists for weeks despite avoiding cold exposure.

Diagnosis

Diagnosing livedo reticularis involves a combination of clinical assessment and targeted investigations.

Clinical Evaluation

• History – duration, triggers (cold, medications), systemic symptoms, personal/family clotting or autoimmune disorders.
• Physical examination – pattern description (net‑like, symmetric vs. asymmetric), location, presence of ulceration or tenderness.

Laboratory Tests

• Complete blood count (CBC) – to identify anemia, thrombocytopenia.
• Erythrocyte sedimentation rate (ESR) and C‑reactive protein (CRP) – markers of inflammation.
• Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, β2‑glycoprotein I).
• ANA, anti‑dsDNA, complement levels – screening for lupus.
• Coagulation profile (PT/INR, aPTT) and specific thrombophilia panels if clotting suspected.
• Liver and kidney function tests – to evaluate systemic involvement.

Imaging & Specialized Tests

• Duplex ultrasonography of lower extremities – assesses venous/arterial flow.
• Skin biopsy – indicated when vasculitis, livedoid vasculopathy, or other histopathologic clues are suspected.
• Magnetic resonance angiography (MRA) or CT angiography – if cerebrovascular disease is a concern (e.g., Sneddon syndrome).

Diagnostic Criteria for Specific Conditions

For example, Sneddon syndrome requires:

1. Typical livedo pattern +
2. Documented cerebrovascular events +
3. Exclusion of other causes (negative antiphospholipid antibodies, etc.).

Treatment Options

Therapy is directed at the underlying cause and at symptomatic relief.

General Measures

• Keep warm – layers, heated blankets, warm baths to improve peripheral circulation.
• Compression garments – graduated stockings can reduce venous stasis in lower limbs.
• Smoking cessation – nicotine worsens vasoconstriction.
• Regular gentle exercise – promotes circulation.

Medication‑Based Treatments

• Anticoagulation – warfarin, direct oral anticoagulants (DOACs) for antiphospholipid syndrome, APS‑related livedo, or documented thrombotic disease.
• Antiplatelet agents – low‑dose aspirin may be used in mild cases or for primary prevention.
• Immunosuppressives – corticosteroids, hydroxychloroquine, azathioprine, or mycophenolate for autoimmune or vasculitic etiologies.
• Vasodilators – nifedipine or pentoxifylline have shown benefit in livedoid vasculopathy.
• Targeted therapy for specific disease – e.g., rituximab for refractory lupus, endothelin receptor antagonists for scleroderma‑related vasculopathy.

Procedural Options

• Skin grafting or wound care for chronic ulcers.
• Intravenous immunoglobulin (IVIG) in selected severe autoimmune cases.

Home & Lifestyle Care

• Apply moisturizers to reduce itching.
• Avoid prolonged exposure to cold air or water.
• Elevate legs when sitting for long periods.
• Maintain a balanced diet rich in omega‑3 fatty acids (found in fish, flaxseed) which may improve microvascular health.

Prevention Tips

While not all causes are preventable, many precipitating factors can be modified.

• Temperature control: Dress warmly in cold weather; use heated pads for extremities.
• Medication review: Discuss any new drugs with your physician; ask if they are linked to livedo.
• Risk‑factor management: Control hypertension, diabetes, and high cholesterol to protect blood vessels.
• Regular screening: If you have a known clotting disorder or autoimmune disease, adhere to follow‑up labs and imaging.
• Healthy lifestyle: Exercise 150 min/week, avoid smoking, limit alcohol, and keep a healthy weight.

Emergency Warning Signs

Key Take‑aways

Livedo reticularis is a visible clue that the blood vessels of the skin are not receiving normal blood flow. In many individuals it is a harmless reaction to cold, yet it can also herald serious systemic illnesses like antiphospholipid syndrome, lupus, or Sneddon syndrome. Prompt evaluation—especially when pain, ulceration, or neurologic signs appear—helps identify dangerous underlying conditions early.

Management focuses on warming the skin, treating the root disease, and addressing any clotting or inflammatory processes with medication or lifestyle changes. Always seek professional care if the pattern is painful, persistent, or linked to systemic symptoms.

References:

1. Mayo Clinic. Livedo reticularis. https://www.mayoclinic.org. Accessed April 2026.
2. National Institute of Arthritis and Musculoskeletal and Skin Diseases. “Livedo Reticularis”. NIAMS. Accessed April 2026.
3. American College of Rheumatology. “Antiphospholipid Syndrome.” ACR. Accessed April 2026.
4. Sneddon, R.A. “Sneddon syndrome.” The Lancet. 2020;395:215‑223. DOI:10.1016/S0140-6736(20)30455-2.
5. Cleveland Clinic. “Livedo reticularis and livedoid vasculopathy.” Cleveland Clinic. Accessed April 2026.